BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Staging
77 results:

  • 1. Alectinib in Resected
    Wu YL; Dziadziuszko R; Ahn JS; Barlesi F; Nishio M; Lee DH; Lee JS; Zhong W; Horinouchi H; Mao W; Hochmair M; de Marinis F; Migliorino MR; Bondarenko I; Lu S; Wang Q; Ochi Lohmann T; Xu T; Cardona A; Ruf T; Noe J; Solomon BJ;
    N Engl J Med; 2024 Apr; 390(14):1265-1276. PubMed ID: 38598794
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Perioperative Durvalumab for Resectable Non-Small-Cell lung cancer.
    Heymach JV; Harpole D; Mitsudomi T; Taube JM; Galffy G; Hochmair M; Winder T; Zukov R; Garbaos G; Gao S; Kuroda H; Ostoros G; Tran TV; You J; Lee KY; Antonuzzo L; Papai-Szekely Z; Akamatsu H; Biswas B; Spira A; Crawford J; Le HT; Aperghis M; Doherty GJ; Mann H; Fouad TM; Reck M;
    N Engl J Med; 2023 Nov; 389(18):1672-1684. PubMed ID: 37870974
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Combined large cell neuroendocrine carcinoma, lung adenocarcinoma, and squamous cell carcinoma: a case report and review of the literature.
    Zhu Z; Liu Y; Xu H; Ning H; Xia Y; Shen L
    J Cardiothorac Surg; 2023 Aug; 18(1):254. PubMed ID: 37653509
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genomic Alterations and the Incidence of Brain Metastases in Advanced and Metastatic NSCLC: A Systematic Review and Meta-Analysis.
    Gillespie CS; Mustafa MA; Richardson GE; Alam AM; Lee KS; Hughes DM; Escriu C; Zakaria R
    J Thorac Oncol; 2023 Dec; 18(12):1703-1713. PubMed ID: 37392903
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. alk rearrangement is an independent predictive factor of unexpected nodal metastasis after surgery in early stage, clinical node negative lung adenocarcinoma.
    Gallina FT; Tajè R; Letizia Cecere F; Forcella D; Landi L; Minuti G; Fusco F; Buglioni S; Visca P; Melis E; Sperduti I; Ciliberto G; Cappuzzo F; Facciolo F
    Lung Cancer; 2023 Jun; 180():107215. PubMed ID: 37126920
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Pretherapy investigations using highly robust visualized biomarkers from CT imaging by multiple machine-learning techniques toward its prognosis prediction for alk-inhibitor therapy in NSCLC: a feasibility study.
    Sun J; Li F; Yang J; Lin C; Zhou X; Liu N; Zhang B; Song G; Wang W; Huang C; Song Z; Shi L
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7341-7353. PubMed ID: 36928998
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The role of brain radiotherapy for EGFR- and alk-positive non-small-cell lung cancer with brain metastases: a review.
    Nardone V; Romeo C; D'Ippolito E; Pastina P; D'Apolito M; Pirtoli L; Caraglia M; Mutti L; Bianco G; Falzea AC; Giannicola R; Giordano A; Tagliaferri P; Vinciguerra C; Desideri I; Loi M; Reginelli A; Cappabianca S; Tassone P; Correale P
    Radiol Med; 2023 Mar; 128(3):316-329. PubMed ID: 36786970
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Diagnostic work-up and systemic treatment for advanced non-squamous non-small-cell lung cancer in four Southeast Asian countries.
    Soo R; Mery L; Bardot A; Kanesvaran R; Keong TC; Pongnikorn D; Prasongsook N; Hutajulu SH; Irawan C; Manan AA; Thiagarajan M; Sripan P; Peters S; Storm H; Bray F; Stahel R
    ESMO Open; 2022 Oct; 7(5):100560. PubMed ID: 35988454
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. IMPORTANCE of PRETREATMENT 18F-FDG PET/CT TEXTURE ANALYSIS in PREDICTING EGFR and alk MUTATION in PATIENTS with NON-SMALL CELL lung cancer.
    Agüloğlu N; Aksu A; Akyol M; Katgı N; Doksöz TÇ
    Nuklearmedizin; 2022 Dec; 61(6):433-439. PubMed ID: 35977671
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Feasibility of EBUS-TBNA for histopathological and molecular diagnostics of NSCLC-A retrospective single-center experience.
    Karadzovska-Kotevska M; Brunnström H; Kosieradzki J; Ek L; Estberg C; Staaf J; Barath S; Planck M
    PLoS One; 2022; 17(2):e0263342. PubMed ID: 35108331
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Deep Learning for Prediction of N2 Metastasis and Survival for Clinical Stage I Non-Small Cell lung cancer.
    Zhong Y; She Y; Deng J; Chen S; Wang T; Yang M; Ma M; Song Y; Qi H; Wang Y; Shi J; Wu C; Xie D; Chen C;
    Radiology; 2022 Jan; 302(1):200-211. PubMed ID: 34698568
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Focused Neck Ultrasound and Lymph Node Sampling by Respiratory Physicians in Suspected lung cancer.
    Hassan M; Nicholson T; Taylor L; McDill H; Hadden R; Syred K; Riordan R; Howell T; Corcoran JP; Daneshvar C
    Respiration; 2022; 101(1):57-62. PubMed ID: 34515221
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Alectinib for an Octogenarian Patient with Poor Performance Status and alk Fusion Gene-Positive lung cancer-A Case Report].
    Kamiyoshihara M; Igai H; Matsuura N; Yazawa T; Ohsawa F
    Gan To Kagaku Ryoho; 2021 Aug; 48(8):1053-1055. PubMed ID: 34404075
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Implementing CT tumor volume and CT pleural thickness into future staging systems for malignant pleural mesothelioma.
    Lauk O; Patella M; Neuer T; Battilana B; Frauenfelder T; Nguyen-Kim TDL; Weder W; Caviezel C; Hillinger S; Inci I; Opitz I
    Cancer Imaging; 2021 Aug; 21(1):48. PubMed ID: 34344472
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Current status of postoperative pathological diagnosis of lung cancer in China: a multicenter big data study].
    ;
    Zhonghua Bing Li Xue Za Zhi; 2021 Aug; 50(8):882-890. PubMed ID: 34344071
    [No Abstract]    [Full Text] [Related]  

  • 16. cancer diagnoses and survival rise as 65-year-olds become Medicare-eligible.
    Patel DC; He H; Berry MF; Yang CJ; Trope WL; Wang Y; Lui NS; Liou DZ; Backhus LM; Shrager JB
    Cancer; 2021 Jul; 127(13):2302-2310. PubMed ID: 33778953
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Pilot Study of the Performance of 19-G Needle in Endobronchial Ultrasound-guided Transbronchial Aspiration for the Diagnosis and Testing of Molecular Markers in lung cancer.
    Wahidi MM; Davidson K; Shofer S; Mahmood K; Cheng G; Giovacchini C; Jones C; Jug R; Pavlisko EN; Wang X; Gu L; Weimholt C; Zhou Z; Chen A
    J Bronchology Interv Pulmonol; 2021 Jul; 28(3):209-214. PubMed ID: 33273249
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic impact of preoperative FDG-PET positive lymph nodes in lung cancer.
    Endoh H; Ichikawa A; Yamamoto R; Shiozawa S; Nishizawa N; Satoh Y; Oriuchi N
    Int J Clin Oncol; 2021 Jan; 26(1):87-94. PubMed ID: 32951076
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Diagnostic Yield of staging Brain MRI in Patients with Newly Diagnosed Non-Small Cell lung cancer.
    Kim M; Suh CH; Lee SM; Kim HC; Aizer AA; Yanagihara TK; Bai HX; Guenette JP; Huang RY; Kim HS
    Radiology; 2020 Nov; 297(2):419-427. PubMed ID: 32840470
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Comprehensive analysis of spread through air spaces in lung adenocarcinoma and squamous cell carcinoma using the 8th edition AJCC/UICC staging system.
    Jia M; Yu S; Yu J; Li Y; Gao H; Sun PL
    BMC Cancer; 2020 Jul; 20(1):705. PubMed ID: 32727513
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.